KU Medical Center-University of Kansas

Kansas City, Kansas 66160-8500

0 studies enrolling now · 3 studies all time

What they study most

Hyposmia, Thyroid Eye Disease

Studies at this site

• A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) — Completed
• Study of CYR-064 Versus Placebo in Patients. — Completed
• A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE ) — Completed